News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
135 Results
Type
Article (25)
Press Release (110)
Section
Business (66)
Deals (13)
Drug Development (14)
FDA (2)
Job Trends (2)
News (84)
Policy (1)
Tag
Alliances (45)
Approvals (2)
Bankruptcy (2)
Best Places to Work (3)
Cancer (11)
Cardiovascular disease (1)
Cell therapy (1)
Clinical research (11)
Collaboration (7)
COVID-19 (1)
Data (2)
Diagnostics (3)
Drug discovery (1)
Earnings (6)
Events (20)
FDA (2)
Gene editing (1)
Government (1)
Healthcare (5)
Immunology and inflammation (1)
Infectious disease (2)
IPO (1)
Liver cancer (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (8)
Neuroscience (1)
NextGen: Class of 2026 (1)
Non-profit (2)
Patient recruitment (2)
People (8)
Phase 1 (6)
Phase 2 (5)
Phase 3 (1)
Pipeline (2)
Preclinical (6)
Prostate cancer (4)
Radiopharmaceuticals (4)
Rare diseases (2)
Regulatory (1)
Startups (1)
Vaccines (1)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (7)
2026 (1)
2025 (8)
2024 (14)
2023 (11)
2022 (5)
2021 (11)
2020 (19)
2019 (16)
2018 (10)
2017 (13)
2016 (14)
2015 (5)
2014 (4)
2013 (2)
2012 (2)
Location
Asia (63)
Europe (27)
Japan (8)
Massachusetts (1)
United States (2)
Wisconsin (1)
135 Results for "peptidream".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan
February 4, 2026
·
6 min read
Press Releases
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
December 18, 2025
·
2 min read
Press Releases
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis
December 18, 2025
·
3 min read
Press Releases
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
October 15, 2025
·
6 min read
Press Releases
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
October 16, 2025
·
3 min read
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company announced an expansion of its peptide discovery collaboration with Swiss-based Novartis Pharma AG.
April 30, 2024
·
3 min read
Press Releases
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
March 31, 2025
·
10 min read
Business
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership
Under the latest teaming between the two companies, who have worked together since 2010, Novartis will pay $180 million upfront to PeptiDream to find new radioligand therapies.
April 30, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
October 2, 2024
·
6 min read
Press Releases
PeptiDream Announces Preclinical Results Demonstrating Efficacy of Oral Myostatin Inhibitors in Preventing Loss of Lean Mass Associated with Semaglutide Treatment
December 12, 2024
·
5 min read
1 of 14
Next
